Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures



Rating:

Share or cite this content

Citations should be made in the following way:
K. Uto (Miyazaki, Japan), S. Yanagi (Miyazaki, Japan), N. Matsumoto (Miyazaki, Japan), M. Nakazato (Miyazaki, Japan). The significance of plasma exchange in the treatment of double-positive for ANCA and anti-GBM disease. 1138

Member's Comments

No comment yet.

Related content which might interest you: Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF) Source: Eur Respir J 2007; 30: Suppl. 51, 648s Year: 2007 Antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in cystic fibrosis (CF) Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 ANCA (antineutrophil cytoplasmic autoantibody) in the chronic lower respiratory tract infection Source: Eur Respir J 2002; 20: Suppl. 38, 444s Year: 2002 The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis Source: Eur Respir J 2011; 37: 1503-1513 Year: 2011 Antineutrophil cytoplasmic antibody (ANCA) associated lung-renal vasculitides: A single centre perspective Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 Differences between ANCA positive and negative lung fibrosis cases without vasculitis Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Successful treatment of antineutrophil cytoplasmic antibody-associated bronchiectasis with immunosuppressive therapy Source: Eur Respir J 2015; 46: 554-557 Year: 2015 There are no correlations between the level of serum antichlamidia antibodies and clinical course of sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 539s Year: 2006 High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003 ANCA positivity is not associated with rheumatoid factor nor with Caplan´s syndrome in silica exposure Source: Eur Respir J 2004; 24: Suppl. 48, 147s Year: 2004 Interstitial lung disease associated with ANCA positivity: a retrospective analysis Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Antinucleosome autoantibody in a patient with sarcoidosis and antiphospholipid antibodies Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010 Cystic lesion in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)- positive interstitial pneumonia: radiological and pathological anaylsis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018 Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Detection of serum anti-endothelial cell antibodies (AECA) in COPD rats Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Pre-transplant soluble CD30 is a stronger predictor of BOS than anti-HLA antibodies occurring after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Antinuclear autoantibodies (ANA) and C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015